Startseite Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy

  • Tashunka Taylor-Miller , Jayne Houghton , Paul Munyard , Yadlapalli Kumar , Clinda Puvirajasinghe und Dinesh Giri EMAIL logo
Veröffentlicht/Copyright: 7. April 2020

Abstract

Background

Congenital hyperinsulinism (CHI), a condition characterized by dysregulation of insulin secretion from the pancreatic β cells, remains one of the most common causes of hyperinsulinemic, hypoketotic hypoglycemia in the newborn period. Mutations in ABCC8 and KCNJ11 constitute the majority of genetic forms of CHI.

Case presentation

A term macrosomic male baby, birth weight 4.81 kg, born to non-consanguineous parents, presented on day 1 of life with severe and persistent hypoglycemia. The biochemical investigations confirmed a diagnosis of CHI. Diazoxide was started and progressively increased to 15 mg/kg/day to maintain normoglycemia. Sequence analysis identified compound heterozygous mutations in ABCC8 c.4076C>T and c.4119+1G>A inherited from the unaffected father and mother, respectively. The mutations are reported pathogenic. The patient is currently 7 months old with a sustained response to diazoxide.

Conclusions

Biallelic ABCC8 mutations are known to result in severe, diffuse, diazoxide-unresponsive hypoglycemia. We report a rare patient with CHI due to compound heterozygous mutations in ABCC8 responsive to diazoxide.


Corresponding author: Dr. Dinesh Giri, Consultant Paediatric Endocrinologist and Honorary Senior Lecturer, Bristol Royal Hospital for Children and University of Bristol, Bristol BS2 8BJ, UK; and Department of Paediatric Endocrinology, Department of Translational Health Sciences, University of Bristol, Bristol, UK, Phone: 01173429336

  1. Author contributions: TTM wrote the first draft of the manuscript and made subsequent revisions until the final version. JH contributed to the genetic aspects and manuscript revisions. CP was involved with cohesion of GenBank reference sequence within the final manuscript. PM and YK were involved in the clinical management and manuscript revisions. DG oversaw the draft, revisions, and the final version. All the authors have approved the final version of the manuscript.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Conflicts of interest: None.

  7. Ethics statement: Our research complies with all relevant national regulations and institutional policies. Informed consent was obtained from the legal guardians of the infant included in this research.

References

1. Kapoor RR, Flanagan SE, Arya V, Shield JP, Ellard S, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013;168:557–64.10.1530/EJE-12-0673Suche in Google Scholar PubMed PubMed Central

2. James C, Kapoor R, Ismail D, Hussain K. The genetic basis of congenital hyperinsulinism. J Med Genet 2009;46:289.10.1136/jmg.2008.064337Suche in Google Scholar PubMed

3. Galcheva S, Demirbilek H, Al-Khawaga S, Hussain K. The genetic and molecular mechanisms of congenital hyperinsulinism. Front Endocrinol 2019;10:111.10.3389/fendo.2019.00111Suche in Google Scholar PubMed PubMed Central

4. Flanagan SE, Kapoor RR, Hussain K. Genetics of congenital hyperinsulinemic hypoglycemia. Semin Pediatr Surg 2011;20:13–17.10.1053/j.sempedsurg.2010.10.004Suche in Google Scholar PubMed

5. Snider K, Becker S, Boyajian L, Shyng -LS, MacMullen C, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98:E355–63.10.1210/jc.2012-2169Suche in Google Scholar PubMed PubMed Central

6. Banerjee I, Skae M, Flanagan S, Rigby L, Patel L, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol 2011;164:733–40.10.1530/EJE-10-1136Suche in Google Scholar PubMed

7. Senniappan S, Arya V, Hussain K. The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocr Metab 2013;17:19–30.10.4103/2230-8210.107822Suche in Google Scholar PubMed PubMed Central

8. Kumaran A, Kapoor RR, Flanagan SE, Ellard S, Hussain K. Congenital hyperinsulinism due to a compound heterozygous abcc8 mutation with spontaneous resolution at eight weeks. Horm Res Paediatr 2010;73:287–92.10.1159/000284394Suche in Google Scholar PubMed

9. Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, et al. Conservatively treated congenital hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. Orphanet J Rare Dis 2016;11:163.10.1186/s13023-016-0547-3Suche in Google Scholar PubMed PubMed Central

10. Shyng S-L, Ferrigni T, Nichols CG. Regulation of KATP channel activity by diazoxide and MgADP distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol 1997;110:643–54.10.1085/jgp.110.6.643Suche in Google Scholar PubMed PubMed Central

11. Larsson O, Ammälä C, Bokvist K, Fredholm B, Rorsman P. Stimulation of the KATP channel by ADP and diazoxide requires nucleotide hydrolysis in mouse pancreatic beta-cells. J Physiol 1993;463:349–65.10.1113/jphysiol.1993.sp019598Suche in Google Scholar PubMed PubMed Central

12. Arya V, Aziz Q, Nessa A, Tinker A, Hussain K. Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy. Int J Pediatr Endocrinol 2014;2014:24.10.1186/1687-9856-2014-24Suche in Google Scholar PubMed PubMed Central

13. MacMullen CM, Zhou Q, Snider KE, Tewson PH, Becker SA, et al. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Diabetes 2011;60:1797–804.10.2337/db10-1631Suche in Google Scholar PubMed PubMed Central

14. Yan F-F, Lin Y-W, MacMullen C, Ganguly A, Stanley CA, et al. Congenital hyperinsulinism-associatedABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels identification and rescue. Diabetes 2007;56:2339–48.10.2337/db07-0150Suche in Google Scholar PubMed PubMed Central

15. Sharma N, Crane A, Clement JP, Gonzalez G, Babenko AP, et al. The C terminus of SUR1 is required for trafficking of KATP channels. J Biol Chem 1999;274:20628–32.10.1074/jbc.274.29.20628Suche in Google Scholar PubMed

16. Powell PD, Bellanné-Chantelot C, Flanagan SE, Ellard S, Rooman R, et al. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy. Diabetes 2011;60:1223–8.10.2337/db10-1443Suche in Google Scholar PubMed PubMed Central

17. Dekel B, Lubin D, Modan-Moses D, Quint J, Glaser B, et al. Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism. Clin Pediatr 2002;41:183–6.10.1177/000992280204100310Suche in Google Scholar PubMed

18. Kiff S, Babb C, Guemes M, Dastamani A, Gilbert C, et al. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation. Endocrinol Diabetes Metab Case Rep 2019;2019. doi:10.1530/edm-18-0120.Suche in Google Scholar PubMed PubMed Central

Received: 2019-10-03
Accepted: 2020-02-18
Published Online: 2020-04-07
Published in Print: 2020-05-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review
  4. Does obesity have an effect on the ECG in children?
  5. Original Articles
  6. Factors associated with oxidative stress status in pediatric patients with type 1 diabetes mellitus
  7. The effect of concurrent resistance-aerobic training on serum cortisol level, anxiety, and quality of life in pediatric type 1 diabetes
  8. Psychiatric view for disorders of sex development: a 12-year experience of a multidisciplinary team in a university hospital
  9. Effect of high-dose vitamin D supplementation on antibody titers to heat shock protein 27 in adolescent girls
  10. Effects of whole-body vibration training on bone density and turnover markers in adolescent swimmers
  11. Estimations of total serum testosterone levels in Nigerian term neonates at birth using anogenital distance measurements
  12. Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing
  13. Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family
  14. Predictive value of thyroxine for prognosis in pediatric septic shock: a prospective observational study
  15. Case Reports
  16. First Scandinavian case of successful pregnancy during nitisinone treatment for type 1 tyrosinemia
  17. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis
  18. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy
  19. Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution
  20. Corrigendum
  21. Corrigendum to: The effects of a 12-week jump rope exercise program on body composition, insulin sensitivity, and academic self-efficacy in obese adolescent girls
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0457/html
Button zum nach oben scrollen